Search in:

Advanced search

Cancer Investigation Volume 9, 1991 - Issue 1

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Original Article

Waldenström's Macroglobulinemia: Long-Term Results with the M-2 Protocol

Delvyn C. Case Divisions of Hematology and Oncology, Departments of Medicine and Biostatistics, Maine Medical Center, Portland, Maine

Thomas J. Ervin Divisions of Hematology and Oncology, Departments of Medicine and Biostatistics, Maine Medical Center, Portland, Maine

Marjorie A. Boyd Divisions of Hematology and Oncology, Departments of Medicine and Biostatistics, Maine Medical Center, Portland, Maine

Dennis L. Redfield Divisions of Hematology and Oncology, Departments of Medicine and Biostatistics, Maine Medical Center, Portland, Maine

Pages 1-7 | Published online: 11 Jun 2009

Cite this article
https://doi.org/10.3109/07357909109032794

References
Citations
Metrics
Reprints & Permissions

References

Waldenström J. Incipient myelomatosis or ‘essential hyperglobulinemia with fibrogenopenia’– A new syndrome. Acta Med Scan 1944; 117: 216
Google Scholar
Waldenström J. Zwei interessante Syndrome mit Hyperglobulinemia. Schweiz Med Wochenschr 1948; 78: 927
PubMedGoogle Scholar
Martin NH. Macroglobulinemia. A clinical and pathological study. Q J Med 1960; 29: 179
PubMedGoogle Scholar
Mackenzie MR, Fudenberg HH. Macroglobulinemia: an analysis of forty patients. Blood 1962; 39: 874
Google Scholar
Cohen RJ, Bohannon RA, Wallerstein RO. Waldenström's macroglobulinemia: Correlation between expanded plasma volume and increased serum viscosity. Blood 1970; 35: 394
PubMed Web of Science ®Google Scholar
McCallister BD, Bayrd ED, Harrison EG, Jr. Primary macroglobulinemia. Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am J Med 1967; 43: 394
Web of Science ®Google Scholar
Stein R, Ellman L, Block KJ. The clinical correlates of IgM M-components: an analysis of thirty-four patients. Am J Med Sci 1975; 269: 209
PubMed Web of Science ®Google Scholar
Krajny M, Prozanski W. Waldenström's macroglobulinemia: review of 45 cases. CMA J 1976; 114: 899
PubMed Web of Science ®Google Scholar
Case DC, Jr, Lee BJ, Clarkson BD. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine, and BCNU: M-2 protocol. Am J Med 1977; 63: 897
PubMed Web of Science ®Google Scholar
Case DC, Jr. Chemotherapy of plasma-cell myeloma. N Engl J Med 1980; 302: 407
PubMed Web of Science ®Google Scholar
Case DC, Jr. Chemotherapy for myeloma. Blood 1980; 55: 1070
PubMedGoogle Scholar
Case DC, Jr., Sonneborn HL, Paul SD, et al. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol). Oncology 1985; 42: 137
PubMed Web of Science ®Google Scholar
Kempin S, Lee B, III, Thaler H, et al. Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol, vincristine, BCNU, cyclophosphamide, melphalan, and prednisone. Blood 1982; 60: 1110
PubMed Web of Science ®Google Scholar
Case DC, Jr., Porensky R, Fanning J. Combination chemotherapy of Stage III and IV chronic lymphocytic leukemia with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone). Oncology 1985; 42: 350
PubMed Web of Science ®Google Scholar
Case DC, Jr. Comparison of COP and M-2 Protocol as therapy for nodular lymphoma. Oncology 1984; 41: 159–163
PubMed Web of Science ®Google Scholar
Case DC, Jr. Combination chemotherapy (M-2 protocol: BCNU, cyclophosphamide, vincristine, melphalan, prednisone) for Waldenström's macroglobulinemia: Preliminary report. Blood 1982; 59: 934
PubMed Web of Science ®Google Scholar
Cancer 1982; 49: 2112
PubMed Web of Science ®Google Scholar
Wright DJ, Jenkins DE, Jr. Simplified method for estimation of serum and plasma viscosity in multiple myeloma and related disorders. Blood 1970; 36: 516
PubMed Web of Science ®Google Scholar
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 157
Web of Science ®Google Scholar
Cox DR. The Analysis of Binary Data. Chapman and Hall, New York 1970
Google Scholar
Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972; 34: 187
Web of Science ®Google Scholar
Olubayede OA, Bademosi O, David-West A, et al. Monoclonal gammopathy (Waldenström's macroglobulinemia) producing specific red cell antibody. J Clin Pathol 1976; 29: 219
PubMed Web of Science ®Google Scholar
Shulman G, Lynch SR, Bezwoda WR, et al. Serum betalipoprotein and other specific protein concentrations in patients with immunocytoma. J Clin Pathol 1976; 29: 458
PubMed Web of Science ®Google Scholar
Naproli VM, Nichols CW, Wright RE. Malignant lymphoma of the nasopharynx in Waldenström's macroglobulinemia: report of a case with severe epistaxis. South Med J 1977; 70: 508
PubMed Web of Science ®Google Scholar
Dalakas MC, Flaum MA, Rick M, et al. Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studies. Neurology 1983; 33: 1406
PubMed Web of Science ®Google Scholar
Krausz Y, Zlatnick A. Macroglobulinemia of Waldenström associated with severe osteolytic lesions. Acta Haematol 1977; 58: 307
PubMed Web of Science ®Google Scholar
Torrey JJ, Katakkar SB. Treatable meningeal involvement in Waldenström's macroglobulinemia. Ann Intern Med 1984; 101: 345
PubMed Web of Science ®Google Scholar
Filuk RB, Warren PW. Broncoalveolar lavage in Waldenström's macroglobulinemia with pulmonary infiltrates. Thorax 1986; 41: 409
PubMedGoogle Scholar
Chelazzi G, Bettini R, Pinatti G. Bone marrow patterns and survival in Waldenström's macroglobulinemia. Lancert 1979; 2: 965
PubMed Web of Science ®Google Scholar
Horsman DE, Card RT, Skinnider LF. Waldenström's macroglobulinemia terminating in acute leukemia: a report of three cases. Am J Hematol 1983; 15: 97
PubMed Web of Science ®Google Scholar
Bruera E, Villamayor R, Roca E, et al. Response of Waldenström's macroglobulinemia to pentostatin (2'-deoxycoformycin). Cancer Treat Rep 1986; 70: 546
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Waldenström's Macroglobulinemia: Long-Term Results with the M-2 Protocol

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Waldenström's Macroglobulinemia: Long-Term Results with the M-2 Protocol

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date